Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-21

FDA Approved: KETOROLAC TROMETHAMINE — Original Application (ATNAHS PHARMA US LIMITED)

View source ↗

Summary

FDA approved a generic ketorolac tromethamine product from ATNAHS PHARMA US LIMITED under Original Application ANDA216407.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)